Mark Mcdade

Mark McDade is a Co-Founder and Partner at Qiming Venture Partners USA, with a background in leading cross-functional teams in the pharmaceutical industry. He has held executive roles at UCB, PDL BioPharma, and Corixa Corporation, and has invested in companies like Icosavax and Talaris Therapeutics. McDade has a strong track record in R&D funding, corporate development, and clinical development, with notable investments in various biopharmaceutical start-ups. His current role at Qiming Venture Partners USA focuses on investing in Series A and Seed stage companies in sectors such as Consumer Health, Digital Health, and Health IT.